Antimicrobial Resistance (AMR)

Microbes are gaining resistance to the treatments used to control them, making antimicrobial resistance one of the greatest current threats to human and animal health. The Institute will investigate the clinical and environmental factors that drive the evolution and development of resistance, and develop novel antimicrobial treatment strategies

Highlights of our research include:

Chickens BroilerDrivers for AMR in Poultry in India (DARPI)

This interdisciplinary project will address the gaps in knowledge by understanding practices on farms, how disease is managed and determining the drivers for the development of AMR in the broiler supply chain. Read more...


Tackling antibiotic overuse in hospitalised children

The BATCH trial will use a personalised approach to safely reduce antibiotic duration in children hospitalised with bacterial infection, through the use of a specific blood test.THe work is being led by Professor Enitan Carrol


lab sceneNovel therapies to tackle AMR

We are developing novel therapies against antimicrobial resistance, including phage based treatment therapies, to reduce the usage of current antimicrobials and to provide realistic and clinically relevant alternatives. Read more...


Actively monitoring pet health in the UK

The Small Animal Veterinary Surveillance Network (SAVSNET) is surveying the health of the UK’s pet population, including looking at antibiotic prescribing in veternary practices. Read more...


Addressing AMR in pneumococcal infections

A new £3M European research project is underway to tackle the emergence and spread of drug-resistant Streptococcus pneumoniae; a major human pathogen causing 1.3 million deaths worldwide annually. Read more...